Form 4 for ICE Intercontinental Exchange
Accepted 2026-09-03 16:30:07 ET · period of report 2026-09-01 · accession 0001193125-26-381954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 16:30 | 2026-09-01 | ICE | Jackson Benjamin | Pres | M - OptEx | $57.31 | +12.9K | 177.1K | +8% | +$737.1K |
| DMT | 2026-09-03 16:30 | 2026-09-01 | ICE | Jackson Benjamin | Pres | S - Sale+OE | $160.09 | -12.9K | 164.3K | -7% | -$2.06M |
| DMT | 2026-09-03 16:30 | 2026-09-01 | ICE | Jackson Benjamin | Pres | M - OptEx | $0.00 | -12.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | M | A | 6,431 | $57.31 | 170,695 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. (F2) Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026. |
| 2 | Common | Common Stock | 2026-09-01 | M | A | 6,431 | $57.31 | 177,126 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. |
| 3 | Common | Common Stock | 2026-09-01 | S | D | 5,020 | $159.68 | 172,106 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. (F3) The price range for the aggregate amount sold by the direct holder is $158.80 - $159.78. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-09-01 | S | D | 6,242 | $160.17 | 165,864 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. (F4) The price range for the aggregate amount sold by the direct holder is $159.80 - $160.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2026-09-01 | S | D | 1,600 | $161.05 | 164,264 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. (F5) The price range for the aggregate amount sold by the direct holder is $160.89 - $161.29. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. (F6) The common stock number referred in Table I is an aggregate number and represents 142,265 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. (F7) The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. (F8) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. |
| 6 | Derivative | Employee Stock Option (right to buy) Holding | 2026-09-01 | M | D | 6,431 | $0.00 | 6,431 | D | $57.31 · — to 2027-01-18 | 6,431 Common Stock | (F9) These options are fully vested. |
| 7 | Derivative | Employee Stock Option (right to buy) Holding | 2026-09-01 | M | D | 6,431 | $0.00 | 0 | D | $57.31 · — to 2027-01-18 | 6,431 Common Stock | (F9) These options are fully vested. |